Cas:3879-08-1 4-hydroxybutyric acid hydrazide manufacturer & supplier

We serve Chemical Name:4-hydroxybutyric acid hydrazide CAS:3879-08-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4-hydroxybutyric acid hydrazide

Chemical Name:4-hydroxybutyric acid hydrazide
CAS.NO:3879-08-1
Synonyms:MFCD00051702;4-hydroxybutanehydrazide
Molecular Formula:C4H10N2O2
Molecular Weight:118.13400
HS Code:2928000090

Physical and Chemical Properties:
Melting point:91-93°C
Boiling point:377.5ºC at 760mmHg
Density:1.161g/cm3
Index of Refraction:1.487
PSA:75.35000
Exact Mass:118.07400
LogP:

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like MFCD00051702 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-hydroxybutanehydrazide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00051702 Use and application,4-hydroxybutanehydrazide technical grade,usp/ep/jp grade.


Related News: He pointed out that Taiwan had 10 confirmed cases, versus more than 14,000 in mainland China. 4-hydroxybutyric acid hydrazide manufacturer The main API products include antihypertensive, psychotropic and anti-AIDS special APIs. Antihypertensive APIs are mainly pulic and sartan drugs, and they are the world’s major suppliers of pulic and sartan APIs. 4-hydroxybutyric acid hydrazide supplier Schimpke, an assistant professor in the Division of Minimally Invasive and Bariatric Surgery at Rush Medical College in Chicago, and his colleagues point out that obesity is linked to a considerably higher risk for developing upwards of 40 different serious illnesses, including heart disease and diabetes. 4-hydroxybutyric acid hydrazide vendor He pointed out that Taiwan had 10 confirmed cases, versus more than 14,000 in mainland China. 4-hydroxybutyric acid hydrazide factory Further research on Oligomannate��s pharmacological mechanism and long-term safety and effectiveness is required, according to the NMPA statement.